Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Risk Assessment generated by a regulatory process
(RA)
last updated: 19 Sep 2023
Risk Assessment Report: Application to Conduct a Confined Field Trial to Test Bioengineered Maize Varieties with Event Mon 89034 (Bt Cry1a.105 And Cry2ab2 Genes) Resistance Against Stemborers and the Fall Armyworm and Event Mon 87460 (Cspb Gene) For Drought Tolerance in Kenya
EN
31 Jul 2023
-
Competent National Authority:National Biosafety Authority ()NACOSTI Building, Loresho, off Waiyaki WayNairobi, Nairobi
28251--00100, KenyaPhone: (+254) (20) (2678667),Fax:Email: info@biosafetykenya.go.ke,Website: https://www.biosafetykenya.go.ke/,
-
MON-8746Ø-4 × MON-89Ø34-3 - TELA® Maize| Bayer Crop Science Company, African Agricultural Technology Foundation and Institute of Agricultural Research | Resistance to antibiotics (Kanamycin), Resistance to diseases and pests (Insects, Lepidoptera (butterflies and moths)), Selectable marker genes and reporter genes, Tolerance to abiotic stress (Cold / Heat, Drought)
EN
| Record type | Field | Record(s) | |
|---|---|---|---|
| Country's Decision or any other Communication | Risk assessment | 1 | |
